UPDATED Sep 27, 2025
Explore the Global Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
GENO | SEK 22.65 | -1.5% | -19.5% | SEK 1.5b | SEK 36.67 | PE55.5x | E34.9% | n/a | ||
IBP | ৳13.50 | -1.5% | 27.4% | ৳1.6b | n/a | PS17.2x | n/a | 0.07% | ||
TEVA | US$18.34 | -0.1% | 5.0% | US$21.0b | US$23.89 | PS1.3x | E31.1% | 0% | ||
300439 | CN¥10.26 | -0.6% | 2.4% | CN¥3.9b | n/a | PE28.9x | n/a | 1.3% | ||
ACCPL | ₹58.80 | -3.5% | n/a | ₹653.6m | n/a | PE9.6x | n/a | n/a | ||
301277 | CN¥12.79 | -0.5% | 29.6% | CN¥5.0b | n/a | PE35.8x | n/a | 2.2% | ||
603139 | CN¥22.20 | -1.1% | 74.8% | CN¥2.2b | n/a | PS4.1x | n/a | 0% | ||
2161 | HK$2.93 | -1.0% | 208.4% | HK$2.4b | HK$3.31 | PE12.1x | E15.9% | 7.8% | ||
FOLD | US$8.24 | -1.0% | -23.1% | US$2.5b | US$15.92 | PS4.4x | E57.9% | n/a | ||
600572 | CN¥4.35 | -0.2% | -4.8% | CN¥10.7b | n/a | PE18x | n/a | 3.4% | ||
531173 | ₹56.72 | -1.0% | 33.4% | ₹2.5b | n/a | PE123.6x | n/a | n/a | ||
300653 | CN¥19.75 | -0.7% | -6.0% | CN¥3.5b | CN¥25.29 | PE36.9x | E15.9% | 2.3% | ||
301281 | CN¥33.60 | -0.7% | 55.3% | CN¥3.6b | n/a | PE54.4x | n/a | 0.6% | ||
600671 | CN¥18.31 | -1.1% | 166.1% | CN¥2.2b | n/a | PE50.7x | n/a | n/a | ||
2644 | CN¥8.61 | -0.6% | 17.0% | CN¥4.4b | n/a | PE81.3x | n/a | 0.1% | ||
HALO | US$73.75 | -0.3% | 29.5% | US$8.6b | US$73.33 | PE15.5x | E14.3% | n/a | ||
6875 | NT$46.00 | -0.4% | -27.0% | NT$5.9b | n/a | PS34.2x | n/a | n/a | ||
6917 | NT$19.90 | -2.9% | 9.3% | NT$902.9m | n/a | n/a | n/a | n/a | ||
4186 | NT$14.15 | -2.1% | -11.0% | NT$1.3b | n/a | PE54.4x | n/a | n/a | ||
ACAD | US$21.05 | -0.8% | 34.2% | US$3.6b | US$29.26 | PE16x | E23.8% | n/a | ||
SILVAPHL | ৳12.50 | -1.6% | -3.1% | ৳1.7b | n/a | PS4x | n/a | 0.8% | ||
8279 | NT$123.50 | -0.8% | -6.4% | NT$3.3b | n/a | PE12x | n/a | 4.0% | ||
MTSR | US$52.25 | -0.5% | n/a | US$5.5b | US$61.00 | PB12.2x | E-20.3% | n/a | ||
ROVI | €56.05 | -1.0% | -22.4% | €2.9b | €79.41 | PE21.7x | E18.2% | 1.7% |